Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
09:00am, Thursday, 04'th Jun 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Dr. Anant Vinjamoori is joining as the Chief Medical Officer of the Him
Hims & Hers Expands With Eucalyptus Acquisition
10:50am, Tuesday, 02'nd Jun 2026
Hims and Hers Health Inc. (HIMS, Financials) completed its acquisition of Eucalyptus, giving the telehealth company a larger international footprint in Australia,
Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World's Largest Consumer Health Platform
06:00am, Tuesday, 02'nd Jun 2026
Hims and Hers Health, Inc. (NYSE: HIMS) has completed its acquisition of Eucalyptus, advancing its position as the world's largest consumer health platform. Buil
Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform
05:00am, Tuesday, 02'nd Jun 2026
SYDNEY--(BUSINESS WIRE)--Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus – the parent company of Juniper, Pilot, Kin, and Software – advancing its position as the world's larg
BERLIN--(BUSINESS WIRE)--Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, advancing its position as the world's largest consumer health platform. In
Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market
05:00am, Tuesday, 02'nd Jun 2026
TOKYO--(BUSINESS WIRE)--Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, marking a significant milestone in the company's global growth and its form
Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World's Largest Consumer Health Platform
05:00am, Tuesday, 02'nd Jun 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) has completed its acquisition of Eucalyptus, advancing its position as the world's largest consumer health platform. Building on t
Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians
05:00am, Tuesday, 02'nd Jun 2026
TORONTO--(BUSINESS WIRE)--Hims & Hers Health, Inc. today announced the completion of its acquisition of Eucalyptus, the parent company of Juniper, marking the latest in a series of significant company
Is Hims & Hers Stock an Undervalued Stock to Buy?
09:08pm, Monday, 01'st Jun 2026
Hims & Hers (HIMS +6.16%) is one of the most volatile stocks in the market.
Hims & Hers Expands Integrated Health Access via Platform Expansion
12:21pm, Friday, 29'th May 2026
HIMS expands its integrated telehealth ecosystem with a new weight-loss membership and a planned Eucalyptus acquisition to broaden virtual care.
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
12:00pm, Thursday, 28'th May 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the expansion of Hims & Hers Benefits, adding eight new partners to the
Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?
09:15am, Thursday, 28'th May 2026
As the market finds itself in the thick of Q2 earnings season, there is—per usual—a considerable amount of noise. Companies that have handily beaten consensus expectations have been punished, whil
Hims & Hers Stock Spikes -- Insider Sends Strong Signal With $1 Million Buy
01:23pm, Wednesday, 27'th May 2026
Hims and Hers Health (HIMS) jumped about 5% on Wednesday after director David Wells disclosed a purchase of more than $1 million in company stock, a move that cam
Hims & Hers Gains 5% on Insider Buying
01:19pm, Wednesday, 27'th May 2026
Hims and Hers Health, Inc. (HIMS) rose 5.07% intraday after director David B. Wells purchased $1.17 million in Class A common stock, acquiring 48,400 shares. Well
HIMS vs. TEM: Which AI Healthcare Stock Offers Better Upside Now?
12:36pm, Wednesday, 27'th May 2026
Hims & Hers and Tempus AI are taking different paths in AI-driven healthcare, but which stock offers stronger upside now? Let's dive in.
